Kang Wu

Kang Wu

Auto-generated profile, based on publicly available information

Kang Wu

Shanghai Pudong New Area Center for Disease Control and Prevention (Shanghai Pudong New Area Health Supervision Institute), Pudong Institute of Preventive Medicine of Fudan University, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
TXTian Xiao
Tian Xiao
HQHua Qiu
Hua Qiu
YCYue Chen
Yue Chen
XZXianfeng Zhou
Xianfeng Zhou
KWKang Wu
Kang Wu
CFChaowei Fu
Chaowei Fu
Chronic obstructive pulmonary disease (COPD) is a serious disease frequently accompanied by anxiety and depression. Few studies have focused on anxiety and depression for mild COPD patients in China. This study aimed to assess the prevalence and associated factors for anxiety and depression among patients with mild COPD in urban communities. A cross-sectional survey of 275 mild COPD patients was conducted in 6 communities randomly sampled from Pudong New Area of Shanghai, China, in 2016. Data on socioeconomic factors and health conditions were acquired through a face-to-face interview as well as a physical examination. The Hospital Anxiety and Depression Scale (HAD) and EQ-5D visual analogue (EQ-5Dvas) were applied to evaluate their mental health and quality of life, respectively. Logistic regression model was used to estimate adjusted odds ratios (aORs) and their 95% confidential intervals (CI) for risk factors associated with anxiety or depression. Among 275 subjects, 8.1% had anxiety and 13.4% had depression. Logistic regression analysis indicated that female patients were more likely to suffer from anxiety than male patients (aOR = 6.41, 95% CI:1.73-23.80). Poor health status (EQ-5Dvas score < 70) was significantly associated with increased risks of anxiety (aOR = 5.99, 95% CI: 2.13-16.82) and depression (aOR = 2.67, 95% CI: 1.29-5.52). There were increased risks of anxiety and depression in mild COPD patients living in urban communities. Female sex and poor health status were significantly correlated to anxiety or depression. More interventions should be developed to reduce the risks of anxiety and depression at the early stage of COPD.

25 June 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
CYChuchu Ye
Chuchu Ye
ZGZHANG GE
ZHANG GE
AZAnran Zhang
Anran Zhang
HXHualei Xin
Hualei Xin
KWKang Wu
Kang Wu
YZYixin Zhou
Yixin Zhou
Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants due to immune escape is challenging for the global response to the pandemic. We estimated the Omicron reinfection prevalence among people who had a previous SARS-CoV-2 infection in Shanghai, China. We conducted a telephone survey in December 2022 with those who had previously been infected with Omicron between March and May 2022. Information on their demographics, coronavirus disease 2019 (COVID-19) testing, and vaccination history was collected. The overall and subgroup reinfection rates were estimated and compared. Among the 1981 respondents who were infected between March and May 2022, 260 had positive nucleic acid or rapid antigen tests in December 2022, with an estimated reinfection rate of 13.1% (95% confidence interval [95% CI]: 11.6–14.6). The reinfection rate for those who had a booster vaccination was 11.4% (95% CI: 9.2–13.7), which was significantly lower than that for those with an incomplete vaccination series (15.2%, 95% CI: 12.3–18.1) (adjusted odds ratio [aOR]: 0.579; 95% CI: 0.412–0.813). Reinfection with the Omicron variant was lower among individuals with a previous SARS-CoV-2 infection and those who had a booster vaccination, suggesting that hybrid immunity may offer protection against reinfection with Omicron sublineages.

30 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
JKJuzhong Ke
Juzhong Ke
XLXiaolin Liu
Xiaolin Liu
XRXiaonan Ruan
Xiaonan Ruan
KWKang Wu
Kang Wu
HQHua Qiu
Hua Qiu
TLTao Lin
Tao Lin
Importance: Sleep duration plays an important role in predicting CCVD incidence, and have implications for reducing the burden of CCVD. However, the association between sleep duration and predicted cardio-cerebral vascular diseases (CCVD)risk remains to be fully understood. Objective: To investigate the effects of sleep duration on the development of CCVD among Chinese community residents. Design: A prospective cohort study. The baseline survey was conducted from January 2013 to July 2013. The cohort has been followed until December 31, 2016 using a combination of in-person interviews and record linkages with the vital registry of Pudong New Area, Shanghai, China. Subjects: A total of 9247 Chinese community residents were initially enrolled in the cohort. Of those, 6476 underwent the follow-up examination. Exposure: Self-reported sleep duration and sleep quality were obtained via the questionnaire. Sleep duration was divided into five categories: ≤5, 6, 7, 8, or≥9 hours per day. Main Outcome(s) and Measure(s): CCVD, Coronary heart disease (CHD) and Stroke occurrence, Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated using Cox proportional hazards models. Results: During a median follow-up of 3.00 years (IQR 2.83-3.08), we observed 393 participants have had incident CCVD events, of whom 216 had CHDs, 148 had strokes, and 29 had both. After adjustment for relevant confounders, short sleepers (≤5h) had 70% higher risk of total CCVD incidence (HR: 1.70; 95%CI: 1.24-2.34), 66% higher risk of CHD incidence (HR: 1.66; 95%CI: 1.11-2.47), and 65% higher risk of stroke incidence (HR: 1.65; 95%CI: 1.03-2.65) in contrast to the reference group (7h). Some of these U-shaped relationships varied by age, and were more pronounced in individuals aged <65 years. Individuals who slept ≤5h per day with baseline hypertension had the highest risk of CCVD incidence (HR: 4.41, 95%CI 2.76-7.04), CHD incidence (HR: 2.52, 95%CI 1.43-4.44), and stroke incidence (HR: 3.72, 95%CI 1.66-8.34), compared with those sleep 7h and without baseline hypertension. Conclusions: Short sleep duration is independently associated with greater incidence of CCVD, CHD and stroke.

16 June 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
QMQiqi Meng
Qiqi Meng
JKJuzhong Ke
Juzhong Ke
XWXiaonan Wang
Xiaonan Wang
HQHua Qiu
Hua Qiu
QLQingping Liu
Qingping Liu
YZYi Zhou
Yi Zhou
Objective: To investigate the prognostic value of the systemic inflammation response index (SIRI) for major adverse cardiovascular events (MACE) among adults with metabolic syndrome (MS), and to determine whether MS status modifies the association between SIRI and incident MACE. Methods: This prospective cohort study enrolled 3,198 participants from Pudong New Area, Shanghai, with a median follow-up of 43 months. Baseline characteristics were compared across SIRI quartiles stratified by MS status. Multivariable Cox proportional hazards regression models were constructed to evaluate the independent association between SIRI and MACE. Restricted cubic spline (RCS) analysis was performed to examine the dose–response relationship. Interaction analyses were conducted to assess effect modification by key metabolic components. Results: Of 3,198 participants, 1,318 had MS and 1,880 did not. Higher SIRI quartiles were associated with unfavorable metabolic profiles in both groups. Compared with non-MS participants in the lowest SIRI quartile, participants with MS in the highest SIRI quartile exhibited the greatest risk of MACE (HR = 2.33, 95% CI: 1.64–3.30, P < 0.001). Among participants with MS, the highest quartile demonstrated a 38% elevated risk compared with the lowest quartile (HR = 1.38, 95% CI: 1.08-1.77, P = 0.01). RCS analysis indicated a linear positive association between SIRI and MACE risk among participants with MS (P for overall association = 0.02). A significant non-linear interaction was identified between SIRI and fasting plasma glucose (P for interaction = 0.04). Conclusion: Elevated SIRI is independently associated with an increased risk of incident MACE, and MS status significantly modifies this association. SIRI represents a promising and readily available biomarker for cardiovascular risk stratification, especially among individuals with MS. Combined interventions targeting systemic inflammation and glycemic control may reduce the risk of MACE in this high-risk population.